Article Text

PDF
Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension
  1. A Micheletti,
  2. A A Hislop,
  3. A Lammers,
  4. P Bonhoeffer,
  5. G Derrick,
  6. P Rees,
  7. S G Haworth
  1. Great Ormond Street Hospital for Children and Institute of Child Health, London, UK
  1. Correspondence to:
    Professor Sheila G Haworth
    Unit of Vascular Biology and Pharmacology, Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK; s.haworth{at}ich.ucl.ac.uk

Abstract

Objectives: To assess in retrospect the safety and effectiveness of atrial septostomy in children with severe pulmonary arterial hypertension without an intracardiac communication.

Methods: 20 patients were reviewed retrospectively, 19 with idiopathic pulmonary arterial hypertension. The mean age at septostomy was 8.4 years (range 3 months to 17 years). Graded balloon septostomy alone was carried out in eight patients, a blade septostomy was done in two, a blade septostomy plus graded balloon septostomy was done in three, and a fenestrated device was inserted in seven.

Results: There were no fatalities. Four children suffered complications during the procedure. None had further syncope and all improved symptomatically with a significant (p < 0.01) decrease in World Health Organization functional class (mean shift −0.6) and a significant improvement in the semiquantitative echocardiographic assessment of right ventricular function (p < 0.03). The mean oxygen saturation decreased by 7.8 percentage points. The atrial communication closed in two children, necessitating a repeat procedure. After a mean follow up of 2.1 years (range one month to 6.7 years), 18 of 20 children are still alive.

Conclusion: Atrial septostomy improved symptoms and quality of life in a group of children deteriorating with severe pulmonary arterial hypertension. This procedure is to be recommended for severely symptomatic children, before they become critically ill. Fenestrated devices may help ensure indefinite patency of the atrial communication.

  • ASD, atrial septal defect
  • IPAH, idiopathic pulmonary arterial hypertension
  • WHO, World Health Organization
  • paediatric pulmonary hypertension
  • idiopathic pulmonary arterial hypertension
  • atrial septostomy

Statistics from Altmetric.com

Footnotes

  • Published Online First 8 November 2005

  • Competing interest statement: Professor SG Haworth is a consultant to Actelion Pharmaceuticals. Dr AA Hislop receives some financial support from the same company.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.